BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23893076)

  • 1. Formation in aqueous solution of a non-oxido V(IV) complex with VN6 coordination. Potentiometric, ESI-MS, spectroscopic and computational characterization.
    Lodyga-Chruscinska E; Szebesczyk A; Sanna D; Hegetschweiler K; Micera G; Garribba E
    Dalton Trans; 2013 Oct; 42(37):13404-16. PubMed ID: 23893076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complex formation of vanadium(IV) with 1,3,5-triamino-1,3,5-trideoxy-cis-inositol and related ligands.
    Morgenstern B; Steinhauser S; Hegetschweiler K; Garribba E; Micera G; Sanna D; Nagy L
    Inorg Chem; 2004 May; 43(10):3116-26. PubMed ID: 15132617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and characterization of vanadium(IV) complexes with cis-inositol in aqueous solution and in the solid-state.
    Morgenstern B; Kutzky B; Neis C; Stucky S; Hegetschweiler K; Garribba E; Micera G
    Inorg Chem; 2007 May; 46(10):3903-15. PubMed ID: 17419616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation of new non-oxido vanadium(IV) species in aqueous solution and in the solid state by tridentate (O, N, O) ligands and rationalization of their EPR behavior.
    Sanna D; Várnagy K; Lihi N; Micera G; Garribba E
    Inorg Chem; 2013 Jul; 52(14):8202-13. PubMed ID: 23819442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectroscopic and potentiometric characterization of oxovanadium(IV) complexes formed by 3-hydroxy-4-pyridinones. Rationalization of the influence of basicity and electronic structure of the ligand on the properties of V(IV)O species in aqueous solution.
    Rangel M; Leite A; João Amorim M; Garribba E; Micera G; Lodyga-Chruscinska E
    Inorg Chem; 2006 Oct; 45(20):8086-97. PubMed ID: 16999406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiometric, spectroscopic, electrochemical and DFT characterization of oxovanadium(IV) complexes formed by citrate and tartrates in aqueous solution at high ligand to metal molar ratios: the effects of the trigonal bipyramidal distortion in bis-chelated species and biological implications.
    Lodyga-Chruscinska E; Sanna D; Garribba E; Micera G
    Dalton Trans; 2008 Sep; (36):4903-16. PubMed ID: 18766223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. V(IV)O versus V(IV) complex formation by tridentate (O, N(arom), O) ligands: prediction of geometry, EPR 51V hyperfine coupling constants, and UV-Vis spectra.
    Pisano L; Várnagy K; Timári S; Hegetschweiler K; Micera G; Garribba E
    Inorg Chem; 2013 May; 52(9):5260-72. PubMed ID: 23581472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complex formation in aqueous solution and in the solid state of the potent insulin-enhancing V(IV)O2+ compounds formed by picolinate and quinolinate derivatives.
    Lodyga-Chruscinska E; Micera G; Garribba E
    Inorg Chem; 2011 Feb; 50(3):883-99. PubMed ID: 21226475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N,N'-ethylenebis(pyridoxylideneiminato) and N,N'-ethylenebis(pyridoxylaminato): synthesis, characterization, potentiometric, spectroscopic, and DFT studies of their vanadium(IV) and vanadium(V) complexes.
    Correia I; Costa Pessoa J; Duarte MT; Henriques RT; Piedade MF; Veiros LF; Jakusch T; Kiss T; Dörnyei A; Castro MM; Geraldes CF; Avecilla F
    Chemistry; 2004 May; 10(9):2301-17. PubMed ID: 15112220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, characterization, X-ray crystal structure, DFT calculations, and catalytic properties of a dioxidovanadium(V) complex derived from oxamohydrazide and pyridoxal: a model complex of vanadate-dependent bromoperoxidase.
    Das C; Adak P; Mondal S; Sekiya R; Kuroda R; Gorelsky SI; Chattopadhyay SK
    Inorg Chem; 2014 Nov; 53(21):11426-37. PubMed ID: 25321493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vanadium(III) complexes with L-cysteine--stability, speciation and the effect on actin in hepatoma Morris 5123 cells.
    Osińska-Królicka I; Podsiadły H; Bukietyńska K; Zemanek-Zboch M; Nowak D; Suchoszek-Łukaniuk K; Malicka-Błaszkiewicz M
    J Inorg Biochem; 2004 Dec; 98(12):2087-98. PubMed ID: 15541498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel V(IV)O-pyrimidinone complex: synthesis, solution speciation and human serum protein binding.
    Gonçalves G; Tomaz I; Correia I; Veiros LF; Castro MM; Avecilla F; Palacio L; Maestro M; Kiss T; Jakusch T; Garcia MH; Pessoa JC
    Dalton Trans; 2013 Sep; 42(33):11841-61. PubMed ID: 23677414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vanadium(IV,V) complexes of D-saccharic and mucic acids in aqueous solution.
    Dornyei A; Garribba E; Jakusch T; Forgo P; Micera G; Kiss T
    Dalton Trans; 2004 Jun; (12):1882-91. PubMed ID: 15381996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VO2+ complexation by bioligands showing keto-enol tautomerism: a potentiometric, spectroscopic, and computational study.
    Sanna D; Varnágy K; Timári S; Micera G; Garribba E
    Inorg Chem; 2011 Oct; 50(20):10328-41. PubMed ID: 21902189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. V(IV)O and Cu(II) complexation by ligands based on pyridine nitrogen donors.
    Sanna D; Buglyó P; Tomaz AI; Costa Pessoa J; Borović S; Micera G; Garribba E
    Dalton Trans; 2012 Nov; 41(41):12824-38. PubMed ID: 22975792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temperature and solvent structure dependence of VO2+ complexes of pyridine-N-oxide derivatives and their interaction with human serum transferrin.
    Sanna D; Ugone V; Micera G; Garribba E
    Dalton Trans; 2012 Jun; 41(24):7304-18. PubMed ID: 22576640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complex formation processes of terminally protected peptides containing two or three histidyl residues. Characterization of the mixed metal complexes of peptides.
    Rajković S; Kállay C; Serényi R; Malandrinos G; Hadjiliadis N; Sanna D; Sóvágó I
    Dalton Trans; 2008 Oct; (37):5059-71. PubMed ID: 18802621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and spectroscopic evidence for the formation of trinuclear and tetranuclear vanadium(III)/carboxylate complexes of acetate and related derivatives in aqueous solution.
    Mukherjee R; Dougan BA; Fry FH; Bunge SD; Ziegler CJ; Brasch NE
    Inorg Chem; 2007 Mar; 46(5):1575-85. PubMed ID: 17279741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chiral vanadium(V) complexes with 2-aminoglucose Schiff-base ligands and their solution configurations: synthesis, structures, and DFT calculations.
    Mohammadnezhad G; Böhme M; Geibig D; Burkhardt A; Görls H; Plass W
    Dalton Trans; 2013 Sep; 42(33):11812-23. PubMed ID: 23760018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidovanadium(IV) Schiff base complex derived from vitamin B6: synthesis, characterization, and insulin enhancing properties.
    Mukherjee T; Costa Pessoa J; Kumar A; Sarkar AR
    Inorg Chem; 2011 May; 50(10):4349-61. PubMed ID: 21495653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.